Time-Restricted Feeding for Circadian Rhythm Disorder
(C2CM Trial)
Trial Summary
What is the purpose of this trial?
Insufficient sleep and circadian misalignment are independent risk factors for the development of obesity and diabetes, yet few strategies exist to counter metabolic impairments when these behaviors are unavoidable. This project will examine whether avoiding food intake during the biological night can mitigate the impact of circadian misalignment on metabolic homeostasis in adults during simulated night shift work. Findings from this study could identify a translatable strategy to minimize metabolic diseases in populations that include anyone working nonstandard hours such as police, paramedics, firefighters, military personnel, pilots, doctors and nurses, truck drivers, and individuals with sleep disorders.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescribed medications, supplements, or illicit drugs at least one month before the study.
What data supports the effectiveness of the treatment Time-Restricted Feeding for Circadian Rhythm Disorder?
Research suggests that time-restricted eating (TRE) can improve metabolic health by reducing body weight, improving glucose tolerance (how well the body processes sugar), and enhancing overall cardiometabolic health. These benefits have been observed in both animal studies and some human studies, indicating potential for managing circadian rhythm disorders.12345
Is time-restricted feeding safe for humans?
How is time-restricted feeding different from other treatments for circadian rhythm disorder?
Time-restricted feeding (TRF) is unique because it focuses on limiting the hours during which you eat each day, aligning meal times with your body's natural circadian rhythms. Unlike other treatments that might involve medication or lifestyle changes, TRF specifically targets the timing of food intake to potentially improve metabolic health and restore natural body rhythms.145910
Eligibility Criteria
This trial is for adults aged 18-35 with a normal weight (BMI of 20.0-24.9), who are moderately active and get about 7-9 hours of sleep nightly, living at high altitudes like Denver for over three months. It's not for those with significant health issues, drug use in the last month, recent shift work or extensive travel, women with certain gynecological conditions or pregnancy, and non-English speakers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a randomized crossover study with time-restricted feeding during circadian misalignment
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Circadian Misalignment
- Time-restricted feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
Colorado State University
Lead Sponsor
University of Colorado, Denver
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Salk Institute for Biological Studies
Collaborator